Cartiheal Is Back: New Cartilage Injury Treatment

Medically reviewed by Dr. Sabrina Strickland, MD · Orthopedic Surgeon, NYU Langone Orthopedic Center · Last reviewed: December 14, 2023

August 29, 2023

I’m happy to report that CartiHeal is back. This is a new treatment for cartilage injury that was FDA approved in 2022 and was initially launched by a large pharmaceutical firm. The banking crisis lead to a temporary halt as the company reverted to the original owner. Today I did the 13th (my third) and the 4th since the relaunch. CartiHeal Agili-C is an FDA approved medical device that can be used to
treat cartilage and joint surface lesions in the knee.

Agili-C, Cartiheal, cartilage injury treatment, FDA-approved, join surface lesions, knee, knee injury, knee treatment, medical device

Considering treatment for a knee or shoulder concern?

Dr. Sabrina Strickland sees patients at NYU Langone Orthopedic Center in New York City. If you would like a personalized evaluation of your symptoms and options, request a consultation below.

Book an appointment Contact the office

Medical Disclaimer. This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified physician regarding any questions about your orthopedic health. Individual results may vary based on diagnosis, anatomy, and overall health.